Keith Manchester

Director/Board Member at ROIVANT SCIENCES LTD.

Net worth: 64 M $ as of 29/09/2026

57 year

58 connections

Health Technology

Finance

Consumer Services

Profile

Keith S.
Manchester is currently an Independent Director at Roivant Sciences Ltd. since 2014, a Director at Roivant Sciences, Inc. since 2014, a Director at Kriya Therapeutics, Inc., and a Partner & Portfolio Manager at QVT Financial LP since 2005.
Former roles include Director at Resolvyx Pharmaceuticals, Inc., Director at Arbutus Biopharma, Inc. from 2014 to 2015, Director at Myovant Sciences Ltd. from 2016 to 2018, Independent Director at Montes Archimedes Acquisition Corp., Independent Director at Arbutus Biopharma Corp.
from 2015 to 2025, Vice President-Business Development at Applied Molecular Evolution, Inc. from 2002 to 2004, Associate at Vestar Capital Partners LLC from 1997 to 1998, Independent Member-Supervisory Board at MediGene AG, and Partner & Head at Life Sciences QVT Financial LP.
Education includes a doctorate from Harvard Medical School and an undergraduate degree from Harvard College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ROIVANT SCIENCES LTD. 0.24%	15/09/2026	1,753,457 ( 0.24% )	64 M $	29/09/2026

Keith Manchester active positions

Companies	Position	Start
ROIVANT SCIENCES LTD.	Director/Board Member	31/12/2013
QVT Financial LP QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology.	Portfolio Manager-Equities	31/12/2004
Roivant Sciences, Inc. Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs	Director/Board Member	31/12/2013
Kriya Therapeutics, Inc. Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases	Director/Board Member	-

All active positions of Keith Manchester

Former positions of Keith Manchester

Companies	Position	End
ARBUTUS BIOPHARMA CORPORATION	Director/Board Member	23/02/2025
MYOVANT SCIENCES LTD.	Director/Board Member	19/09/2018
Arbutus Biopharma, Inc. Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions	Director/Board Member	28/02/2015
VCP I Inc VCP I Inc Investment ManagersFinance Vestar Capital invests in companies located in the United States. The firm targets companies operating in the fields of consumer, healthcare and business & technology services. It provides financing for buyout, MBO, carve-outs and growth capital requirements. It acquires control or makes minority investments.	Corporate Officer/Principal	30/12/1998
ROIVANT SCIENCES LTD.	Director/Board Member	-

See the detail of Keith Manchester's experience

Education of Keith Manchester

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith Manchester's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	15
Applied Molecular Evolution, Inc. Applied Molecular Evolution, Inc. BiotechnologyHealth Technology Develops and manufactures proteins & genes for commercial purposes	Health Technology
QVT Financial LP QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology.	Finance
Resolvyx Pharmaceuticals, Inc. Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for inflammatory diseases	Health Technology
Arbutus Biopharma Corp. Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases	Health Technology
Arbutus Biopharma, Inc. Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions	Health Technology
Roivant Sciences Ltd. Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases	Health Technology
VCP I Inc VCP I Inc Investment ManagersFinance Vestar Capital invests in companies located in the United States. The firm targets companies operating in the fields of consumer, healthcare and business & technology services. It provides financing for buyout, MBO, carve-outs and growth capital requirements. It acquires control or makes minority investments.	Finance
MediGene AG MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard College Harvard College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Myovant Sciences Ltd. Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions	Health Technology
Roivant Sciences, Inc. Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs	Health Technology
Life Sciences Qvt Financial LP
Kriya Therapeutics, Inc. Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases	Health Technology
Montes Archimedes Acquisition Corp. Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance